Form DEFA14A Catalent, Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 3, 2024 (May 2, 2024)
CATALENT, INC.
(Exact name of registrant as specified in its charter)
Delaware 001-36587 20-8737688 (State or other jurisdictionof Incorporation)
Form 6-K Haoxi Health Technology For: May 03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2024
Commission File Number: 001-41933
Haoxi Health Technology Limited
Room 801, Tower C, Floor 8, Building 103, Huizhongli, Chaoyang District
Beijing, China
+86-10-13311587976
(Address of principal executive offices)
Form 4 Harmony Biosciences Hold For: May 01 Filed by: Budur Kumar
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form 10-Q CUMULUS MEDIA INC For: Mar 31
-
Form 10-Q SHENANDOAH TELECOMMUNICA For: Mar 31
-
Form ARS Foghorn Therapeutics For: Dec 31
-
Form 8-K CUMULUS MEDIA INC For: May 03
-
Form 424B2 BofA Finance LLC
-
Form 10-Q Shake Shack Inc. For: Mar 27
-
Form 10-Q SCI Engineered Materials For: Mar 31
-
Form DEFA14A Foghorn Therapeutics
-
Form 8-K Digital Brands Group, For: Apr 30
-
Form SC TO-I/A Evanston Alternative Filed by: Evanston Alternative Opportunities Fund
-
Form 8-K AMERICAN AXLE & MANUFACT For: May 03
-
Form 8-K Catalent, Inc. For: May 02
-
Form S-3ASR Keros Therapeutics, Inc.
-
Form 8-K Cidara Therapeutics, For: May 03
-
Form DEF 14A Foghorn Therapeutics For: Jun 26
-
Form 8-K Sonnet BioTherapeutics For: May 02
-
Form 8-K/A HOLOGIC INC For: May 02
-
Form 8-K Harmony Biosciences Hold For: May 01
-
Form 6-K Immuron Ltd For: May 03
-
Form DEF 14A SeaStar Medical Holding For: May 03
-
Form N-CSRS Columbia Funds Series For: Feb 29
-
Form 13F-HR COWEN AND COMPANY, LLC For: Mar 31
-
Form 8-K IES Holdings, Inc. For: May 03
-
Form 8-K Perella Weinberg Partner For: May 03
-
Form 10-Q ONESPAWORLD HOLDINGS For: Mar 31
-
Form N-CSR Columbia Funds Series For: Feb 29
-
Form D 42 North Private Holding
-
Form 10-Q IES Holdings, Inc. For: Mar 31
-
Form 10-Q TELEPHONE & DATA SYSTEMS For: Mar 31
-
Form 8-K/A TALOS ENERGY INC. For: Mar 04
-
Form DEFA14A HALLIBURTON CO
-
Form S-8 Burke & Herbert Financia
-
Form 10-Q HOLOGIC INC For: Mar 30
-
Form 6-K MAGNA INTERNATIONAL INC For: Mar 31
-
Form 8-K HALLIBURTON CO For: May 02
-
Form 10-Q Federal Home Loan Bank For: Mar 31
-
Form 10-Q UNITED STATES CELLULAR For: Mar 31
-
Form DEFA14A CROWN CASTLE INC.
-
Form 8-K CHART INDUSTRIES INC For: May 03
-
Form DEFA14A CROWN CASTLE INC.
-
Form 8-K TELEPHONE & DATA SYSTEMS For: May 03
-
Form 8-K fuboTV Inc. /FL For: May 03
-
Form 10-Q Fulgent Genetics, Inc. For: Mar 31
-
Form 8-K UNITED STATES CELLULAR For: May 03
-
Form 8-K Cheniere Energy Partners For: May 03
-
Form 8-K Cheniere Energy, Inc. For: May 03
-
Form 10-Q SANDY SPRING BANCORP For: Mar 31
-
Form 8-K Burke & Herbert Financia For: May 03
-
Form 8-K CONX Corp. For: May 02
-
Form ARS Lantern Pharma Inc. For: Dec 31
